Combination therapy with IL-2 and wild-type p53 expressed by Ad-vectors induces tumor regression in vivo without cytokine related toxicity
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 1, 1997
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Cancer Gene Therapy Journal